Skip to contentSkip to Braille Studio

Library / Laws / 114th Congress / Senate Bills / S. 3056

S. 3056

To provide for certain causes of action relating to delays of generic drugs and biosimilar biological products.

Print stageDateSize⠃
Introduced in Senate2016-06-1421.3K⠃⠗⠋